首页> 外文期刊>Histopathology: Official Journal of the British Division of the International Academy of Pathology >High expression of heat shock proteins and heat shock factor‐1 distinguishes an aggressive subset of clear cell renal cell carcinoma
【24h】

High expression of heat shock proteins and heat shock factor‐1 distinguishes an aggressive subset of clear cell renal cell carcinoma

机译:热休克蛋白和热休克因子-1的高表达区分透明细胞肾细胞癌的侵略性子集

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aims Heat shock proteins ( HSP s) are a group of molecules induced by a variety of environmental and pathophysiological stresses, including cancer. HSPs are implicated in the regulation of apoptosis and immunity in neoplasm. Transcription factor heat shock factor 1 ( HSF 1) acts as the master regulator to control HSP expression, and is therefore involved in tumorigenesis. The purpose of this study was to evaluate the expression and clinicopathological relevance of HSP s and HSF 1 in clear cell renal cell carcinoma (cc RCC ). Methods and results The expression of HSP 27, HSP 60, HSP 70, HSP 90 and HSF 1 was assessed in 428 cases of cc RCC using immunohistochemistry. High expression of HSP 60 and HSP 70 was correlated positively with grade and stage. High expression of HSF 1 was correlated positively with stage. Univariate and multivariate analyses demonstrated that 216 patients (52%) with tumour expressing three or four markers in a panel of HSP 60, HSP 70, HSP 90 and HSF 1 had a significantly heightened risk for cancer‐specific mortality than tumours expressing fewer than three markers ( P ??0.0001; concordance index, 0.81). Conclusions Immunohistochemical examination of HSP s and HSF 1 provides useful prognostic information that may contribute to the design of therapeutic strategies for patients with cc RCC .
机译:AIMS热休克蛋白(HSP S)是由各种环境和病理生理胁迫引起的一组分子,包括癌症。 HSP涉及调节肿瘤中的细胞凋亡和免疫力。转录因子热休克因子1(HSF 1)用作控制HSP表达的主调节剂,因此涉及肿瘤发生。本研究的目的是评估HSP S和HSF 1在透明细胞肾细胞癌(CC RCC)中的表达和临床病理相关性。方法和结果在使用免疫组织化学的428例CC RCC的428例中评估了HSP 27,HSP 60,HSP 70,HSP 90和HSF 1的表达。 HSP 60和HSP 70的高表达与等级和阶段正相关。 HSF 1的高表达与阶段正相关。单变量和多变量分析证明,216名患者(52%)在HSP 60,HSP 70,HSP 90和HSF 1面板中表达三个或四个标记的肿瘤,对癌症特异性死亡率显着提高,而不是表达少于三个的肿瘤标记(p?& 0.0001;一致性指数,0.81)。结论HSP S和HSF 1的免疫组化检查提供了有用的预后信息,可能有助于CC RCC患者的治疗策略设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号